Literature DB >> 16831588

Proportion of de novo cancers among colorectal cancers in Japan.

Hideyo Goto1, Yasushi Oda, Yoshitaka Murakami, Tomofumi Tanaka, Kiwamu Hasuda, Sayoko Goto, Yutaka Sasaki, Shotaro Sakisaka, Masahiro Hattori.   

Abstract

BACKGROUND & AIMS: Adenomatous polyps are main precursors of colorectal cancers (CRCs). In Japan, de novo cancers, which do not arise from preexisting adenomas, are considered to account for a substantial number of CRCs, but the relative importance of de novo carcinogenesis remains controversial. This study estimated the proportion of de novo cancers among CRCs in Japan.
METHODS: The subjects were persons 40-79 years of age who were relatively similar to those in the general population. The subjects underwent colonoscopy between 1997 and 2001. Early cancers among CRCs detected in this study were classified as de novo cancers or polyp cancers derived from adenomas. The age-specific incidence of the early CRCs was calculated, and the proportion of de novo cancers was estimated. The lifetime risk of early CRCs was estimated.
RESULTS: The study group comprised 14,817 persons. CRCs were diagnosed in 189 subjects, including 83 early cancers. There were no differences with regard to size and location between de novo cancers and polyp cancers, but morphology differed. Eighty-four percent (16/19) of de novo cancers were flat elevated or depressed. The expected lifetime risk of developing early CRCs was 5.27% for men and 3.21% for women. Among persons with early cancers, the expected probabilities of developing de novo cancer were 18.6% for men, 27.4% for women.
CONCLUSIONS: De novo cancers account for a considerable proportion in Japan. This information suggests that the recommended interval for colonoscopic examination in Japan should be shorter than that in the United States.

Entities:  

Mesh:

Year:  2006        PMID: 16831588     DOI: 10.1053/j.gastro.2006.04.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Clinicopathological differences of laterally spreading tumors arising in the colon and rectum.

Authors:  Hideaki Miyamoto; Hiroaki Ikematsu; Satoshi Fujii; Shozo Osera; Tomoyuki Odagaki; Yasuhiro Oono; Tomonori Yano; Atsushi Ochiai; Yutaka Sasaki; Kazuhiro Kaneko
Journal:  Int J Colorectal Dis       Date:  2014-07-03       Impact factor: 2.571

2.  APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.

Authors:  Yohei Kojima; Kouki Ohtsuka; Hiroaki Ohnishi; Nobutsugu Abe; Junji Furuse; Takashi Watanabe; Masanori Sugiyama
Journal:  Surg Today       Date:  2018-03-10       Impact factor: 2.549

Review 3.  Transparent cap colonoscopy versus standard colonoscopy to improve caecal intubation.

Authors:  Jenna Morgan; Kathryn Thomas; Heather Lee-Robichaud; Richard L Nelson; Sarah Braungart
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Polyp surveillance.

Authors:  W Donald Buie; Anthony R MacLean
Journal:  Clin Colon Rectal Surg       Date:  2008-11

5.  Clinicopathological differences of colorectal cancers according to tumor origin: Identification of possibly de novo lesions.

Authors:  Petros C Papagiorgis; Adamantia E Zizi; Sophia Tseleni; Ioannis N Oikonomakis; Nikolaos I Nikiteas
Journal:  Biomed Rep       Date:  2012-10-09

6.  Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE.

Authors:  Ambinintsoa H Ralaidovy; Chaitra Gopalappa; André Ilbawi; Carel Pretorius; Jeremy A Lauer
Journal:  Cost Eff Resour Alloc       Date:  2018-10-29

7.  TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors.

Authors:  Eiji Sakai; Masaki Fukuyo; Keisuke Matsusaka; Ken Ohata; Noriteru Doi; Kiyoko Takane; Nobuyuki Matsuhashi; Junichi Fukushima; Atsushi Nakajima; Atsushi Kaneda
Journal:  Cancer Sci       Date:  2016-04-27       Impact factor: 6.716

8.  iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors.

Authors:  Xianfei Wang; Aimin Li; Yubin Guo; Yadong Wang; Xinhua Zhao; Li Xiang; Zelong Han; Yue Li; Wen Xu; Kangmin Zhuang; Qun Yan; Jietao Zhong; Jing Xiong; Side Liu
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

9.  Copy Number Alterations of Depressed Colorectal Neoplasm Predict the Survival and Response to Oxaliplatin in Proximal Colon Cancer.

Authors:  Li-Chun Chang; Han-Mo Chiu; Bing-Ching Ho; Min-Hsuan Chen; Yin-Chen Hsu; Wei-Tzu Chiu; Kang-Yi Su; Chia-Tung Shun; Jin-Tung Liang; Sung-Liang Yu; Ming-Shiang Wu
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.